Gyre Therapeutics, Inc. GYRE Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s software and technology licenses, net?
- Gyre Therapeutics, Inc. (GYRE) reported software and technology licenses, net of $4.94M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Gyre Therapeutics, Inc.'s software and technology licenses, net decreased by 11.1% year-over-year, from $5.56M to $4.94M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s software and technology licenses, net has grown at a 57.1% compound annual growth rate (CAGR), from $528K to $5.05M.